Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 118

1.

Versorgungsforschung in der Uroonkologie – Von der Last zur Lust auf Daten.

König F, Johannsen M, Klier J, Schönfelder R, Eichenauer R, Rexer H, Gschwend J, Suttmann H, Doehn C.

Aktuelle Urol. 2018 Apr;49(2):125. doi: 10.1055/s-0044-101694. Epub 2018 Mar 27. German. No abstract available.

PMID:
29587317
2.

Pazopanib Exposure Relationship with Clinical Efficacy and Safety in the Adjuvant Treatment of Advanced Renal Cell Carcinoma.

Sternberg CN, Donskov F, Haas NB, Doehn C, Russo P, Elmeliegy M, Baneyx G, Banerjee H, Aimone P, Motzer RJ.

Clin Cancer Res. 2018 Jul 1;24(13):3005-3013. doi: 10.1158/1078-0432.CCR-17-2652. Epub 2018 Jan 12.

PMID:
29330204
3.

Randomized Phase III Trial of Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma.

Motzer RJ, Haas NB, Donskov F, Gross-Goupil M, Varlamov S, Kopyltsov E, Lee JL, Melichar B, Rini BI, Choueiri TK, Zemanova M, Wood LA, Reaume MN, Stenzl A, Chowdhury S, Lim HY, McDermott R, Michael A, Bao W, Carrasco-Alfonso MJ, Aimone P, Voi M, Doehn C, Russo P, Sternberg CN; PROTECT investigators.

J Clin Oncol. 2017 Dec 10;35(35):3916-3923. doi: 10.1200/JCO.2017.73.5324. Epub 2017 Sep 13.

4.

[An open single-arm phase II monotherapy study of pembrolizumab (MK-3475) in locally advanced/metastatic renal cell carcinoma (mRCC) (Keynote 427) - AN 40/16 of the AUO].

Rexer H, Doehn C, Bedke J.

Urologe A. 2017 Jul;56(7):928-929. doi: 10.1007/s00120-017-0422-4. German. No abstract available.

PMID:
28616640
5.

The PAZOREAL noninterventional study to assess effectiveness and safety of pazopanib and everolimus in the changing metastatic renal cell carcinoma treatment landscape.

Goebell PJ, Doehn C, Grüllich C, Grünwald V, Steiner T, Ehneß R, Welslau M.

Future Oncol. 2017 Jul;13(17):1463-1471. doi: 10.2217/fon-2017-0083. Epub 2017 May 19.

6.

[Interdisciplinary Recommendations for the Treatment of Metastatic Renal Cell Carcinoma].

Miller K, Bergmann L, Doehn C, Gschwend J, Keilholz U.

Aktuelle Urol. 2017 Feb;48(1):72-78. doi: 10.1055/s-0042-117572. Epub 2017 Apr 12. German.

PMID:
28403496
7.

Effect of an interactive cardiopulmonary resuscitation assist device with an automated external defibrillator synchronised with a ventilator on the CPR performance of emergency medical service staff: a randomised simulation study.

Nitzschke R, Doehn C, Kersten JF, Blanz J, Kalwa TJ, Scotti NA, Kubitz JC.

Scand J Trauma Resusc Emerg Med. 2017 Apr 4;25(1):36. doi: 10.1186/s13049-017-0379-8.

8.

In Reply.

Doehn C, Weikert S.

Dtsch Arztebl Int. 2017 Mar 3;114(9):160. doi: 10.3238/arztebl.2017.0160b. No abstract available.

9.

The Diagnosis, Treatment, and Follow-up of Renal Cell Carcinoma.

Doehn C, Grünwald V, Steiner T, Follmann M, Rexer H, Krege S.

Dtsch Arztebl Int. 2016 Sep 5;113(35-36):590-6. doi: 10.3238/arztebl.2016.0590. Review.

11.

Providers with Limited Experience Perform Better in Advanced Life Support with Assistance Using an Interactive Device with an Automated External Defibrillator Linked to a Ventilator.

Busch CW, Qalanawi M, Kersten JF, Kalwa TJ, Scotti NA, Reip W, Doehn C, Maisch S, Nitzschke R.

J Emerg Med. 2015 Oct;49(4):455-63. doi: 10.1016/j.jemermed.2015.03.020. Epub 2015 May 30.

PMID:
26037479
12.

Everolimus in metastatic renal cell carcinoma after failure of initial anti-VEGF therapy: final results of a noninterventional study.

Bergmann L, Kube U, Doehn C, Steiner T, Goebell PJ, Kindler M, Herrmann E, Janssen J, Weikert S, Scheffler MT, Schmitz J, Albrecht M, Staehler M.

BMC Cancer. 2015 Apr 18;15:303. doi: 10.1186/s12885-015-1309-7.

13.

[Interdisciplinary recommendations for the treatment of metastatic renal cell carcinoma].

Miller K, Bergmann L, Doehn C, Grünwald V, Gschwend J, Kuczyk M.

Aktuelle Urol. 2015 Mar;46(2):151-7. doi: 10.1055/s-0035-1547281. Epub 2015 Apr 21. Review. German.

PMID:
25897537
14.

Everolimus in metastatic renal cell carcinoma after failure of initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor (VEGFr-TKI) therapy: results of an interim analysis of a non-interventional study.

Bergmann L, Goebell PJ, Kube U, Kindler M, Herrmann E, Janssen J, Schmitz J, Weikert S, Steiner G, Jakob A, Staehler MD, Steiner T, Overkamp F, Albrecht M, Guderian G, Doehn C.

Onkologie. 2013;36(3):95-100. doi: 10.1159/000348522. Epub 2013 Feb 25.

PMID:
23485996
15.

[Active surveillance for renal cell carcinoma].

Doehn C, Witzsch U, Siebels M.

Aktuelle Urol. 2012 Jul;43(4):243-9. doi: 10.1055/s-0032-1321828. Epub 2012 Aug 6. Review. German.

PMID:
22869494
16.

[Endourological imaging with narrow band imaging].

Doehn C.

Urologe A. 2012 Jun;51(6):784-90. doi: 10.1007/s00120-012-2896-4. German.

PMID:
22674508
17.

Laparoscopic versus open bilateral nephrectomy in transplant recipients with medication-resistant hypertension: final results of a multicenter study with 15 years of follow-up.

Wagner S, Greco F, Doehn C, Hoda MR, Girndt M, Jocham D, Fornara P.

Transplant Proc. 2011 Sep;43(7):2557-61. doi: 10.1016/j.transproceed.2011.04.011.

PMID:
21911122
18.

[Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer].

Neumann A, Keller T, Jocham D, Doehn C.

Aktuelle Urol. 2011 Sep;42(5):311-5. doi: 10.1055/s-0031-1271545. Epub 2011 Aug 1. German.

PMID:
21809268
19.

[How accurate is the correlation between clinical and pathological TNM stages in renal tumours?].

Frommhold J, Jocham D, Doehn C.

Aktuelle Urol. 2011 Jul;42(4):247-51. doi: 10.1055/s-0031-1271392. Epub 2011 Jun 29. German.

PMID:
21717400
20.

[Metastatic renal cell cancer in Germany in 2010. Impact of different target therapies].

Siebels M, Hegele A, Varga Z, Oberneder R, Doehn C, Heinzer H; Deutsche Gesellschaft für Immun- und Targeted Therapie e.V. (DGFIT).

Urologe A. 2011 Sep;50(9):1110-7. doi: 10.1007/s00120-011-2553-3. German.

PMID:
21559917
21.

Laparoscopic adrenalectomy in urological centres - the experience of the German Laparoscopic Working Group.

Greco F, Hoda MR, Rassweiler J, Fahlenkamp D, Neisius DA, Kutta A, Thüroff JW, Krause A, Strohmaier WL, Bachmann A, Hertle L, Popken G, Deger S, Doehn C, Jocham D, Loch T, Lahme S, Janitzky V, Gilfrich CP, Klotz T, Kopper B, Rebmann U, Kälbe T, Wetterauer U, Leitenberger A, Rassler J, Kawan F, Inferrera A, Wagner S, Fornara P.

BJU Int. 2011 Nov;108(10):1646-51. doi: 10.1111/j.1464-410X.2010.10038.x. Epub 2011 Apr 6.

22.

[Ureteropelvic junction obstruction with renal hypertension].

Kazarians B, Cordes J, Jocham D, Doehn C.

Aktuelle Urol. 2011 May;42(3):190-2. doi: 10.1055/s-0031-1271420. Epub 2011 Mar 24. German.

PMID:
21437865
23.

Results of secondary ureteral implantation after kidney transplantation.

Doehn C, Böse N, Meyer AJ, Jocham D.

Int Urol Nephrol. 2011 Sep;43(3):669-74. doi: 10.1007/s11255-010-9893-6. Epub 2011 Jan 23.

PMID:
21259050
24.

Comparison between a 1.92-μm fiber laser and a standard HF-dissection device for nephron-sparing kidney resection in a porcine in vivo study.

Theisen-Kunde D, Tedsen S, Doehn C, Jocham D, Kausch von Schmeling I.

Lasers Med Sci. 2011 Jul;26(4):509-14. doi: 10.1007/s10103-010-0873-y. Epub 2011 Jan 18.

PMID:
21243512
25.

Outcome analysis of fornix ruptures in 162 consecutive patients.

Doehn C, Fiola L, Peter M, Jocham D.

J Endourol. 2010 Nov;24(11):1869-73. doi: 10.1089/end.2010.0018. Epub 2010 Oct 15.

PMID:
20950139
26.

Whose transplant function fails after ureteral revision following kidney transplantation?

Doehn C, Böse N, Meyer A, Jocham D.

Transplant Proc. 2010 Jun;42(5):1716-8. doi: 10.1016/j.transproceed.2010.01.075.

PMID:
20620508
27.

Hot topics in kidney cancer 2010.

Merseburger AS, Ljungberg B, Doehn C.

World J Urol. 2010 Jun;28(3):245-6. doi: 10.1007/s00345-010-0564-0. Epub 2010 May 5. No abstract available.

PMID:
20443008
28.

[Stromal tumour of uncertain malignant potential of the prostate (STUMP) - a case report].

Laturnus JM, Gebhard M, Sommerauer M, Jocham D, Doehn C.

Aktuelle Urol. 2010 May;41(3):197-9. doi: 10.1055/s-0029-1224735. Epub 2010 Mar 4. German.

PMID:
20205073
29.

[Report on the 17th Annual Congress of the Working Party on Renal Transplantation. Training and further education commission of German Urologists, Academy of German Urologists, Lübeck 12-14 November 2009].

Sommerauer M, Küster J, Steiner T, Dreikorn K, Heynemann H, Giessing M, Doehn C.

Urologe A. 2010 May;49(5):655-8. doi: 10.1007/s00120-010-2228-5. German. No abstract available.

PMID:
20182689
30.

[Causes and course of fornix rupture].

Doehn C, Fiola L, Peter M, Jocham D.

Aktuelle Urol. 2010 Mar;41(2):119-21. doi: 10.1055/s-0030-1247252. Epub 2010 Feb 9. German.

PMID:
20146172
31.

[Atypical metastasis of renal cell carcinoma. Contribution of comparative genomic hybridisation to diagnosis].

Kazarians B, Kausch I, Noack F, Junker K, Jocham D, Doehn C.

Urologe A. 2010 Mar;49(3):407-10. doi: 10.1007/s00120-009-2213-z. German.

PMID:
20094700
32.

The role of surgery in clinical management of patients with metastatic papillary renal cell carcinoma.

Steiner T, Kirchner H, Siebels M, Doehn C, Heynemann H, Varga Z, Rohde D, Schubert J, Jocham D, Stief C, Fornara P, Hofmann R, Loening S, Roigas J.

J Cancer Res Clin Oncol. 2010 Jun;136(6):905-10. doi: 10.1007/s00432-009-0732-z. Epub 2009 Dec 12.

PMID:
20012752
33.

[Impact of immunotherapy in metastatic kidney cancer in Germany after introduction of new target therapy--results of a telephone survey of the German Society of Immuno- and Targeted Therapy (DGFIT)].

Siebels M, Staehler M, Hegele A, Varga Z, Oberneder R, Doehn C, Heinzer H; Deutsche Gesellschaft für Immun- und Targeted Therapie e.V. (DGFIT).

Aktuelle Urol. 2010 Mar;41(2):122-30. doi: 10.1055/s-0029-1224676. Epub 2009 Nov 20. German.

PMID:
19937556
34.

Words of wisdom. Re: the efficacy and safety of degarelix: a 12-month, comparative, randomized, open- label, parallel-group phase III study in patients with prostate cancer.

Jocham D, Doehn C.

Eur Urol. 2009 Jun;55(6):1488-9. No abstract available. Erratum in: Eur Urol. 2009 Nov;56(5):e40. Dosage error in article text.

PMID:
19650242
35.

Degarelix and its therapeutic potential in the treatment of prostate cancer.

Doehn C, Sommerauer M, Jocham D.

Clin Interv Aging. 2009;4:215-23. Epub 2009 May 14. Review.

36.

Degarelix for prostate cancer.

Doehn C, Sommerauer M, Jocham D.

Expert Opin Investig Drugs. 2009 Jun;18(6):851-60. doi: 10.1517/13543780902954713. Review.

PMID:
19453267
37.

Re: Genitofemoral nerve injury after laparoscopic varicocelectomy in adolescents. O. J. Muensterer. J Urol 2008; 180: 2155-2158.

Doehn C.

J Urol. 2009 Jun;181(6):2828; author reply 2828. doi: 10.1016/j.juro.2009.02.055. Epub 2009 Apr 22. No abstract available.

PMID:
19395031
38.

In vivo studies on the availability and toxicity of antisense oligonucleotides in bladder cancer.

Blietz CE, Thode B, Hauses M, Pries R, Meyer AJ, Doehn C, Jocham D, Kausch I.

In Vivo. 2009 Jan-Feb;23(1):13-9.

39.

Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery.

Bensalah K, Pantuck AJ, Rioux-Leclercq N, Thuret R, Montorsi F, Karakiewicz PI, Mottet N, Zini L, Bertini R, Salomon L, Villers A, Soulie M, Bellec L, Rischmann P, De la Taille A, Avakian R, Crepel M, Ferriere JM, Bernhard JC, Dujardin T, Pouliot F, Rigaud J, Pfister C, Albouy B, Guy L, Joniau S, van Poppel H, Lebret T, Culty T, Saint F, Zisman A, Raz O, Lang H, Spie R, Wille A, Roigas J, Aguilera A, Rambeaud B, Martinez Piñeiro L, Nativ O, Farfara R, Richard F, Roupret M, Doehn C, Bastian PJ, Muller SC, Tostain J, Belldegrun AS, Patard JJ.

Eur Urol. 2010 Mar;57(3):466-71. doi: 10.1016/j.eururo.2009.03.048. Epub 2009 Mar 31.

PMID:
19359089
40.

[BCG versus photodynamic therapy (PDT) for nonmuscle invasive bladder cancer-a multicentre clinical phase III study].

Jocham D, von Wietersheim J, Pflüger H, Steiner H, Doehn C, Büttner H, Böhle A, Kausch I.

Aktuelle Urol. 2009 Mar;40(2):91-9. doi: 10.1055/s-0028-1098741. Epub 2009 Feb 12. German.

PMID:
19214951
41.

Does adjuvant vitespen prevent recurrence in patients with locally advanced kidney cancer?

Doehn C, Jocham D.

Nat Clin Pract Urol. 2008 Dec;5(12):644-5. doi: 10.1038/ncpuro1256. Epub 2008 Nov 11. No abstract available.

PMID:
19002125
42.

[Squamous cell carcinoma of the renal pelvis. Therapeutic options for a rare entity].

Kazarians B, Kausch I, Doehn C, Jocham D.

Aktuelle Urol. 2008 Nov;39(6):456-8. doi: 10.1055/s-2008-1038233. Epub 2008 Oct 31. German.

PMID:
18979401
43.

Mode-of-action, efficacy, and safety of a homologous multi-epitope vaccine in a murine model for adjuvant treatment of renal cell carcinoma.

Doehn C, Esser N, Pauels HG, Kiessig ST, Stelljes M, Grossmann A, Jocham D, Drevs J.

Eur Urol. 2009 Jul;56(1):123-31. doi: 10.1016/j.eururo.2008.05.034. Epub 2008 Jun 4.

PMID:
18550267
44.

Prostate cancer vaccines: current status and future potential.

Doehn C, Böhmer T, Kausch I, Sommerauer M, Jocham D.

BioDrugs. 2008;22(2):71-84. Review.

PMID:
18345705
45.

Immunotherapy of prostate cancer.

Doehn C.

Eur Urol. 2008 Apr;53(4):681-3; discussion 684-5. doi: 10.1016/j.eururo.2007.12.038. Epub 2008 Jan 3. No abstract available. Erratum in: Eur Urol. 2008 Jun;53(6):1321.

PMID:
18248878
46.

[New drugs for metastatic kidney cancer].

Doehn C.

Aktuelle Urol. 2008 Jan;39(1):41-52. doi: 10.1055/s-2007-1016432. Review. German.

PMID:
18228187
47.

[Localized amyloidosis of the ureter].

Kazarians B, Kausch I, Meyer A, Krüger S, Doehn C, Jocham D.

Urologe A. 2007 Dec;46(12):1718-20. German.

PMID:
17938876
48.

[Spontaneous hemorrhage of the adrenal gland during pregnancy].

Kazarians B, Kausch I, Gellissen J, Doehn C, Jocham D.

Aktuelle Urol. 2007 Sep;38(5):403-5. German. Erratum in: Aktuelle Urol. 2007 Nov;38(6):475.

PMID:
17907068
49.

[Is there an indication for neoadjuvant or adjuvant systemic therapy in renal cell cancer?].

Doehn C, Merseburger AS, Jocham D, Kuczyk MA.

Urologe A. 2007 Oct;46(10):1371-2, 1374, 1376-8. German.

PMID:
17805507
50.

Drug evaluation: Therion's rV-PSA-TRICOM + rF-PSA-TRICOM prime-boost prostate cancer vaccine.

Doehn C, Kausch I, Böhmer T, Sommerauer M, Jocham D.

Curr Opin Mol Ther. 2007 Apr;9(2):183-9.

PMID:
17458173

Supplemental Content

Support Center